CLINICAL EXPERIENCE WITH THE ANTICOAGULANT PANWARFIN (WARFARIN SODIUM)
- Warfarin testing every 12 weeks? Elliott, William T. // Primary Care Reports;Jan2012 Pharmacology Watch, p1
The article reports on a study which suggested testing on warfarin, an anticoagulant, may be safely done in stable patients every 12 weeks instead of the usual four-week interval. According to the study, patients in the 12-week group had fewer dose changes and secondary outcomes such as major...
- Warfarin testing every 12 weeks? // Clinical Cardiology Alert;Jan2012 Pharmacology Watch, p1
The article reports a study on the effect of increasing warfarin dosing which concluded that assessment of warfarin dosing every 12 weeks seems to be safe and noninferior, although further study is recommended.
- Predicting Dose Response. Davies, Kevin // Bio-IT World;Sep2007, Vol. 6 Issue 7, p6
The article stresses the difficulty of predicting the response by people on the dosage of drugs administered to them. It notes that the drug label of anti-coagulant warfarin, which is considered one of the most commonly prescribed drugs in the U.S., will be revised to note the value of genetic...
- ANTICOAGULANT DOSING CONVERSIONS. // Monthly Prescribing Reference;Fall2013, p62
The article offers information on dosing conversions in anticoagulants. It mentions the conversion from Dabigtran to Warfarin and also informs about the use of parentral anticoagulant after switching from dabigtran. It mentions that the administration of Warfarin is based on creatinine clearance...
- A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in... Gedge, Jennifer; Orme, Susie // Age & Ageing;Jan2000, Vol. 29 Issue 1, p31
Presents information on a study which compared a low-dose warfarin induction regimen with the Fennerty regimen to reduce over-anticoagulation among elderly inpatients. Uses of warfarin; Subjects and methods used in the study; Results and conclusion.
- Treating Clotting Disorders: A Balance between Preventing Clots and Bleeding. // Women's Health Advisor;Feb2013, Vol. 17 Issue 2, p3
The article focuses on positive and negative effect of anticoagulant drugs on human body. It informs about a study on warfarin, an anticoagulant drug that shows bleeding rates from the drug are higher than in clinical trials, and often are fatal depending on the amount of dose of drug that a...
- Anticoagulation of older patients: a need to modify current practice. Loh, Pei Chong; Morgan, Kathy; Wynne, Hilary // Age & Ageing;Nov2000, Vol. 29 Issue 6, p551
Examines the practice of using anticoagulation drugs in older patients. Clinical practices regarding medication; Discussion on the need to modify the use of warfarin drug induction regimen; Results of a modified induction regimen among elderly patients.
- The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers. Faaij, R. A.; van Griensven, J. M. T.; Schoemaker, R. C.; Goggin, T.; Guenzi, A.; Kroon, J. M.; Burggraaf, J.; Cohen, A. F. // European Journal of Clinical Pharmacology;Apr2001, Vol. 57 Issue 1, p25
Objective: The effect of oral warfarin on the pharmacokinetics and pharmacodynamics of the synthetic direct thrombin inhibitor napsagatran was investigated. Methods: In an open, randomised, two-way crossover study, 12 healthy male volunteers were infused napsagatran (80 Âµg/min) for 48 h. Each...
- Warfarin testing every 12 weeks? // Clinical Oncology Alert;Jan2012 Supplement, p1
The article discusses a study which revealed that patients on a stable dose of warfarin for 6 months can be safely assessed for warfarin at 12-week intervals, instead of the recommended 4-week interval.